Randomized Phase II Study of Thalidomide Versus Thalidomide Plus Fludarabine for Patients With Chronic Lymphocytic Leukemia Previously Treated With Fludarabine
Phase of Trial: Phase II
Latest Information Update: 05 Jun 2013
At a glance
- Drugs Fludarabine (Primary) ; Thalidomide (Primary)
- Indications Haematological malignancies
- Focus Adverse reactions; Therapeutic Use
- 05 Jun 2013 Status changed from completed to discontinued as reported by ClinicalTrials.gov.
- 19 Jan 2007 Status changed from recruiting
- 02 Sep 2005 New trial record.